Bellecapital International Ltd. Purchases 2,874 Shares of Intuitive Surgical, Inc. $ISRG

Bellecapital International Ltd. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 113.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,410 shares of the medical equipment provider’s stock after purchasing an additional 2,874 shares during the period. Bellecapital International Ltd.’s holdings in Intuitive Surgical were worth $2,420,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Tobam lifted its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical during the second quarter worth about $27,000. 1248 Management LLC bought a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $30,000. Finally, Riggs Asset Managment Co. Inc. grew its holdings in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $577.81 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company’s fifty day moving average is $555.54 and its two-hundred day moving average is $507.11. The company has a market capitalization of $207.13 billion, a P/E ratio of 76.43, a PEG ratio of 5.28 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the company posted $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the sale, the executive vice president owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 114,007 shares of company stock worth $63,533,844. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. Leerink Partners lifted their price target on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Jefferies Financial Group boosted their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Piper Sandler raised their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. BTIG Research boosted their price target on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $611.08.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.